Most Read Articles
Roshini Claire Anthony, 4 days ago

Patients undergoing chemotherapy for breast or haematological cancers could potentially reduce their risk of chemotherapy-related cardiotoxicity with the use of angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor antagonists (ARBs), or beta-blockers as primary prevention, according to a systematic review and meta-analysis presented at the recent EuroEcho 2019 conference.

Roshini Claire Anthony, 3 days ago

Undergoing bariatric surgery to treat obesity may also improve subclinical heart function, according to a small study presented at the EuroEcho 2019 conference.

Pearl Toh, 06 Dec 2019
Getting just under one extra hour of sleep per night can go a long way for the health of college students, who are often sleep-deprived, a study suggests.
3 days ago
Women who had experienced physical and emotional abuse during childhood appear to have a significantly higher risk of systemic lupus erythematosus (SLE) than those who had not, a recent study reveals. Exposure to childhood adversity may be a risk factor for SLE development.

Product Highlight - Cybec

27 Sep 2019

Active Ingredient: Celecoxib

  • Indications: Management of acute & chronic OA & RA, acute pain & low back pain. Primary dysmenorrhea. Relief of signs & symptoms of ankylosing spondylitis.
  • Dosage & Administration: OA 200 mg as single dose. RA 200 mg bid. Acute pain & primary dysmenorrhea Initially 400 mg followed by an additional 200 mg on the 1st day; subsequently 200 mg bid or 400 mg once daily, as needed. Ankylosing spondylitis 200 mg as single dose up to a total daily dose of 400 mg. Low back pain 200 mg or 400 mg daily as single dose or 200 mg bid.
  • Presentation: Cap 200 mg x 1 x 10’s, 10 x 10’s.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Thailand digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

Patients undergoing chemotherapy for breast or haematological cancers could potentially reduce their risk of chemotherapy-related cardiotoxicity with the use of angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor antagonists (ARBs), or beta-blockers as primary prevention, according to a systematic review and meta-analysis presented at the recent EuroEcho 2019 conference.

Roshini Claire Anthony, 3 days ago

Undergoing bariatric surgery to treat obesity may also improve subclinical heart function, according to a small study presented at the EuroEcho 2019 conference.

Pearl Toh, 06 Dec 2019
Getting just under one extra hour of sleep per night can go a long way for the health of college students, who are often sleep-deprived, a study suggests.
3 days ago
Women who had experienced physical and emotional abuse during childhood appear to have a significantly higher risk of systemic lupus erythematosus (SLE) than those who had not, a recent study reveals. Exposure to childhood adversity may be a risk factor for SLE development.